TMSRX vs. RMDFX
Compare and contrast key facts about T. Rowe Price Multi-Strategy Total Return Fund (TMSRX) and Aspiriant Defensive Allocation Fund (RMDFX).
TMSRX is managed by T. Rowe Price. It was launched on Feb 22, 2018. RMDFX is managed by Aspiriant. It was launched on Dec 13, 2015.
Performance
TMSRX vs. RMDFX - Performance Comparison
Loading graphics...
TMSRX vs. RMDFX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
TMSRX T. Rowe Price Multi-Strategy Total Return Fund | 0.41% | 2.95% | 5.36% | 5.09% | -4.69% | -2.08% | 13.21% | 7.59% | -4.11% |
RMDFX Aspiriant Defensive Allocation Fund | 2.53% | 18.85% | 1.45% | 8.01% | -6.84% | 4.20% | 5.10% | 11.50% | -6.11% |
Returns By Period
In the year-to-date period, TMSRX achieves a 0.41% return, which is significantly lower than RMDFX's 2.53% return.
TMSRX
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.41%
- 6M
- 1.50%
- 1Y
- 2.93%
- 3Y*
- 4.31%
- 5Y*
- 1.16%
- 10Y*
- —
RMDFX
- 1D
- 0.25%
- 1M
- -3.79%
- YTD
- 2.53%
- 6M
- 7.56%
- 1Y
- 17.15%
- 3Y*
- 9.46%
- 5Y*
- 5.23%
- 10Y*
- 4.91%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
TMSRX vs. RMDFX - Expense Ratio Comparison
TMSRX has a 1.19% expense ratio, which is higher than RMDFX's 0.18% expense ratio.
Return for Risk
TMSRX vs. RMDFX — Risk / Return Rank
TMSRX
RMDFX
TMSRX vs. RMDFX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Multi-Strategy Total Return Fund (TMSRX) and Aspiriant Defensive Allocation Fund (RMDFX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TMSRX | RMDFX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.41 | 3.47 | -2.06 |
Sortino ratioReturn per unit of downside risk | 1.85 | 4.74 | -2.89 |
Omega ratioGain probability vs. loss probability | 1.36 | 1.75 | -0.39 |
Calmar ratioReturn relative to maximum drawdown | 1.50 | 4.07 | -2.57 |
Martin ratioReturn relative to average drawdown | 5.92 | 17.19 | -11.28 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| TMSRX | RMDFX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.41 | 3.47 | -2.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | 0.83 | -0.41 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.79 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.84 | 0.78 | +0.06 |
Correlation
The correlation between TMSRX and RMDFX is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
TMSRX vs. RMDFX - Dividend Comparison
TMSRX's dividend yield for the trailing twelve months is around 9.49%, more than RMDFX's 4.52% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
TMSRX T. Rowe Price Multi-Strategy Total Return Fund | 9.49% | 7.59% | 6.72% | 5.95% | 2.29% | 2.88% | 3.35% | 3.00% | 3.56% | 0.00% | 0.00% |
RMDFX Aspiriant Defensive Allocation Fund | 4.52% | 4.63% | 0.00% | 3.69% | 0.78% | 5.37% | 2.28% | 3.78% | 4.11% | 2.16% | 1.16% |
Drawdowns
TMSRX vs. RMDFX - Drawdown Comparison
The maximum TMSRX drawdown since its inception was -10.67%, smaller than the maximum RMDFX drawdown of -15.96%. Use the drawdown chart below to compare losses from any high point for TMSRX and RMDFX.
Loading graphics...
Drawdown Indicators
| TMSRX | RMDFX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -10.67% | -15.96% | +5.29% |
Max Drawdown (1Y)Largest decline over 1 year | -1.84% | -4.19% | +2.35% |
Max Drawdown (5Y)Largest decline over 5 years | -10.59% | -14.63% | +4.04% |
Max Drawdown (10Y)Largest decline over 10 years | — | -15.96% | — |
Current DrawdownCurrent decline from peak | -0.16% | -3.79% | +3.63% |
Average DrawdownAverage peak-to-trough decline | -2.79% | -3.37% | +0.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.50% | 0.99% | -0.49% |
Volatility
TMSRX vs. RMDFX - Volatility Comparison
The current volatility for T. Rowe Price Multi-Strategy Total Return Fund (TMSRX) is 0.00%, while Aspiriant Defensive Allocation Fund (RMDFX) has a volatility of 1.99%. This indicates that TMSRX experiences smaller price fluctuations and is considered to be less risky than RMDFX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| TMSRX | RMDFX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 1.99% | -1.99% |
Volatility (6M)Calculated over the trailing 6-month period | 1.44% | 3.83% | -2.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 2.10% | 5.01% | -2.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 2.79% | 6.34% | -3.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 3.31% | 6.20% | -2.89% |